Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 1986Pacing and Clinical Electrophysiology

The Automatic Implantable Cardioverter Defibrillator: Results, Observations, and Comments

View Full Paper
Ask AI
Bookmark
Share

Key result

AICD use is linked to ~10% mortality and multiple complications requiring reoperation.

  • n=21

Why the study?

Does the automatic implantable cardioverter-defibrillator (AICD) improve survival in patients with recurrent ventricular dysrhythmias?

Population

21 patients with recurrent ventricular dysrhythmias

Design

Case_series

Follow-up

3-35 months (mean 19)

Authors

RLRichard M. LuceriElectrophysiologyRTRichard J. ThurerUniversity of MiamiGPGeorge M. PalatianosOnassis Cardiac Surgery Center

Discussion

Loading...

Member takes

Implication

Early AICD experience shows deaths and reoperations; leaves open net survival benefit in recurrent ventricular dysrhythmias.

Key Points

  • To assess the clinical efficacy, complication rates, and survival outcomes of patients receiving an automatic implantable cardioverter-defibrillator for recurrent life-threatening ventricular dysrhythmias.
  • Evaluated an initial clinical cohort of 21 patients (N=21) receiving an automatic implantable cardioverter-defibrillator (AICD) for recurrent ventricular dysrhythmias.
  • Tracked clinical outcomes, survival, and device interactions over a follow-up period ranging from 3 to 35 months (mean 19 months).
  • Two total patient deaths occurred during the observation period: one nonarrhythmic death at month 5 and one arrhythmic death at month 10 postoperatively.
  • Five complications requiring surgical reoperation occurred in 3 patients, and 4 patients concurrently required permanent pacemakers.

Study Design

Type

Observational (n=21)

Multicenter

No

Structured PICO

Does the automatic implantable cardioverter-defibrillator (AICD) improve survival in patients with recurrent ventricular dysrhythmias?

P
Population
21 patients with recurrent ventricular dysrhythmias implanted with an AICD, followed for a mean of 19 months.
E
Exposure
Automatic implantable cardioverter-defibrillator (AICD)
O
Outcome
Survival and complicationshard clinical

Early single-center experience with the AICD supports its use for improving survival in selected patients with recurrent ventricular dysrhythmias.

Cite This Study

Luceri et al. (1986) conducted an observational in Recurrent ventricular dysrhythmias (n=21). Automatic implantable cardioverter-defibrillator (AICD) was evaluated on Death. The automatic implantable cardioverter-defibrillator (AICD) resulted in two deaths (9.5%) and five complications requiring reoperation among 21 patients over a mean follow-up of 19 months.

synapsesocial.com/papers/6aa85228a2ea35927a1e957dhttps://doi.org/10.1111/j.1540-8159.1986.tb06721.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator.1985 · 452 citations
  2. 2Mortality in Patients with Implanted Automatic Defibrillators1983 · 311 citations
  3. 3Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human Beings1980 · 1,366 citations
  4. 4Treatment of Malignant Ventricular Arrhythmias with Endocardial Resection and Implantation of the Automatic Cardioverter-Defibrillator1986 · 95 citations
  5. 5The Impact of the Automatic Implantable Cardioverter Defibrillator on Quality of Life1986 · 58 citations